Acadian Asset Management
CGEM icon

Acadian Asset Management’s Cullinan Oncology CGEM Stock Holding History

Acadian Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+20,279
New +$301K ﹤0.01% 1519
2025
Q2 		– Sell
-81,721
Closed -$618K – 1676
2025
Q1 		$618K Buy
+81,721
New +$784K ﹤0.01% 1039
2024
Q4 		– Sell
-956
Closed -$16K – 1697
2024
Q3 		$16K Buy
+956
New +$17K ﹤0.01% 2002
2023
Q1 		– Sell
-16,927
Closed -$178K – 1763
2022
Q4 		$178K Sell
16,927
-9,974
-37% -$121K ﹤0.01% 1309
2022
Q3 		$344K Buy
+26,901
New +$362K ﹤0.01% 1090

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Acadian Asset Management's CGEM Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 20,279 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in CGEM as recently as Q1 2025.

Acadian Asset Management first reported a position in CGEM in Q3 2022 and has held it in 5 quarters since. The position peaked at $618K in Q1 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Acadian Asset Management held 20,279 shares of Cullinan Oncology worth $366K as of Q2 2026.
  • Cullinan Oncology was a new Acadian Asset Management position in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1519 holding.
  • Acadian Asset Management first reported a position in Cullinan Oncology in Q3 2022 and has held it in 5 quarters since.
  • Acadian Asset Management's Cullinan Oncology position peaked at $618K in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.